Sign In   |   Register
News: Publications

Commentary September: Cholesterol & inflammatory risk: insights from secondary & primary prevention

Thursday 27 September 2018   (0 Comments)
Share |

Low-density lipoprotein cholesterol is indisputably causal for cardiovascular disease, and a major modifiable risk factor. Results from the CANTOS trial also indicate the relevance of inflammatory risk. Both types of risk are important in secondary and primary prevention settings, as discussed in this commentary.

To the commentary by Jane Stock>>

Membership Software Powered by YourMembership  ::  Legal